XML 31 R54.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Details) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities $ 4,575 $ 3,609
Net cash (used) provided by operating activities 116,664 174,460
Payments to Acquire Businesses, Gross (27,742) 0
Investing Activities:    
Capital expenditures (30,323) (23,749)
Net cash used in investing activities (53,490) (20,140)
Financing Activities:    
Payments for Repurchase of Common Stock (152,735) (27,055)
Proceeds from (Payments for) Other Financing Activities 175 (8,301)
Net cash used in financing activities (18,082) (124,820)
Effect of exchange rate changes on cash and cash equivalents (3,275) (4,693)
Net change in cash and cash equivalents 41,817 24,807
Cash and cash equivalents at the beginning of period 96,343 117,953
Cash and cash equivalents at the end of period 138,160 142,760
Parent Company [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities 0 0
Net cash (used) provided by operating activities 9,480 14,198
Payments to Acquire Businesses, Gross 0  
Investing Activities:    
Capital expenditures 0 0
Proceeds from Dividends Received 0 0
Net cash used in investing activities 0 0
Financing Activities:    
Borrowings 143,255 12,857
Repayments 0 0
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0
Payments for Repurchase of Common Stock (152,735) 27,055
Proceeds from (Payments for) Other Financing Activities 0 0
Net cash used in financing activities (9,480) (14,198)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 0 0
Cash and cash equivalents at the beginning of period 0 0
Cash and cash equivalents at the end of period 0 0
Guarantor Subsidiaries [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities (210,320) (81,128)
Net cash (used) provided by operating activities 210,707 62,439
Payments to Acquire Businesses, Gross (27,742)  
Investing Activities:    
Capital expenditures (13,269) (12,831)
Proceeds from Dividends Received 67,065 118,271
Net cash used in investing activities (184,266) 24,312
Financing Activities:    
Borrowings 333,418 246,323
Repayments (344,167) (318,323)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0
Payments for Repurchase of Common Stock   0
Payments for Repurchase of Private Placement 0  
Proceeds from (Payments for) Other Financing Activities (13,734) (8,301)
Net cash used in financing activities (24,483) (80,301)
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 1,958 6,450
Cash and cash equivalents at the beginning of period 35,931 50,602
Cash and cash equivalents at the end of period 37,889 57,052
Non-Guarantor Subsidiaries [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities 4,575 3,609
Net cash (used) provided by operating activities (103,523) 97,823
Payments to Acquire Businesses, Gross 0  
Investing Activities:    
Capital expenditures (17,054) (10,918)
Proceeds from Dividends Received 0 0
Net cash used in investing activities (12,479) (7,309)
Financing Activities:    
Borrowings 856,464 933,046
Repayments (630,263) (882,239)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees (67,065) (118,271)
Payments for Repurchase of Common Stock 0 0
Proceeds from (Payments for) Other Financing Activities 0 0
Net cash used in financing activities 159,136 (67,464)
Effect of exchange rate changes on cash and cash equivalents (3,275) (4,693)
Net change in cash and cash equivalents 39,859 18,357
Cash and cash equivalents at the beginning of period 60,412 67,351
Cash and cash equivalents at the end of period 100,271 85,708
Consolidated Entities [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities 4,575 3,609
Net cash (used) provided by operating activities 116,664 174,460
Payments to Acquire Businesses, Gross (27,742)  
Investing Activities:    
Capital expenditures (30,323) (23,749)
Proceeds from Dividends Received 0 0
Net cash used in investing activities (53,490) (20,140)
Financing Activities:    
Borrowings 1,122,817 1,111,098
Repayments (974,430) (1,200,562)
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees 0 0
Payments for Repurchase of Common Stock 152,735 27,055
Proceeds from (Payments for) Other Financing Activities (13,734) (8,301)
Net cash used in financing activities (18,082) (124,820)
Effect of exchange rate changes on cash and cash equivalents (3,275) (4,693)
Net change in cash and cash equivalents 41,817 24,807
Cash and cash equivalents at the beginning of period 96,343 117,953
Cash and cash equivalents at the end of period 138,160 142,760
Consolidation, Eliminations [Member]    
Condensed Financial Information [Line Items]    
Payments for (Proceeds from) Other Investing Activities 210,320 81,128
Net cash (used) provided by operating activities 0 0
Payments to Acquire Businesses, Gross 0  
Investing Activities:    
Capital expenditures 0 0
Proceeds from Dividends Received (67,065) (118,271)
Net cash used in investing activities 143,255 (37,143)
Financing Activities:    
Borrowings (210,320) (81,128)
Repayments 0 0
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Subsidiaries and Equity Method Investees (67,065) (118,271)
Payments for Repurchase of Common Stock 0 0
Proceeds from (Payments for) Other Financing Activities 0 0
Net cash used in financing activities (143,255) 37,143
Effect of exchange rate changes on cash and cash equivalents 0 0
Net change in cash and cash equivalents 0 0
Cash and cash equivalents at the beginning of period 0 0
Cash and cash equivalents at the end of period $ 0 $ 0